MAP2K2 and atherosclerosis: Lnc000048 regulates the expression of MAP2K2 (mitogen-activated protein kinase 2) by inhibiting the demethylation activity of LSD1 to promote the phosphorylation level of ERK and ultimately affects the atherosclerosis process in mice.103